Why the Pharmaceutical Industry is Booming in Japan - SPONSOR CONTENT FROM THE GOVERNMENT OF JAPAN

Harvard Business Review

That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The biggest change for pharma in Japan was the 2014 revision of the nation’s keystone pharmaceuticals law, renamed the PMD Act—for pharmaceutical and medical devices. Older people need more medicine.

It’s Time to Rein in Exorbitant Pharmaceutical Prices

Harvard Business Review

As the ire over high prescription drug prices in the United States escalates , it’s easy to blame pharmaceutical companies. But pharmaceutical companies aren’t to blame. There are compelling reasons, however, to consider doing so for pharmaceuticals.

Complexity is the New Normal in Healthcare Communications Today


Whether you are a highly matrixed, multisite healthcare system undergoing a merger, or global pharmaceutical or medical device company expanding its portfolio, the common thread is complexity.

Innovation Is as Much About Finding Partners as Building Products

Harvard Business Review

This is the challenge for all kinds of disruptors, whether in the auto industry, pharmaceuticals, service industries, or healthcare. But the startup could not keep pace with the development and scale of established battery makers, and production defects led to a $55 million recall in 2012 and contributed to the company’s bankruptcy later that year. Innovation Product development Regulation Digital Article

Shame On Our Apology Economy

Lead Change Blog

Valeant/Philidor pharmaceutical companies. And this list doesn’t include those who really didn’t apologize like Sepp Blatter, former FIFA president; Martin Shkreli, former CEO, Turing Pharmaceuticals; or recently ousted Pennsylvania Attorney General Kathleen Kane).

Price Gouging and the Dangerous New Breed of Pharma Companies

Harvard Business Review

For 78-year-old Tony, 3,4 DAP — which can be obtained at low cost from compounding pharmacies or for free through a compassionate-use program supported by a small privately held company, Jacobus Pharmaceuticals — is a lifesaver.

The Mylan EpiPen Debacle: How Tremendous Greed Can Lead to the Demise of a Leader

N2Growth Blog

As you have likely heard, the pharmaceutical company Mylan and its CEO, Heather Bresch, have come under immense scrutiny for the firm’s EpiPen pricing policy. And against that, manufacturing the product, distributing the product, enhancing the product, investing.”

Price 195

3 Business Models That Could Bring Million-Dollar Cures to Everyone

Harvard Business Review

Put another way, product classes with fundamentally new performance profiles can’t be dropped into an existing business model and expected to work. Innovation Business models Entrepreneurship Healthcare Pharmaceuticals Technology Digital Article

The Right Kind of Conflict Leads to Better Products

Harvard Business Review

When partners in an alliance come into conflict, it can be just what is needed to produce a technically and commercially successful product. ” Lilly recently analyzed fourteen years of data to understand the relationship between the health of these alliances (as evidenced by the ratings on the survey) and the technical and commercial success of the products on which they worked. ” This idea that disagreement and conflict between groups can be productive is not new.

Make Your Knowledge Workers More Productive

Harvard Business Review

With scarcely any help from management, knowledge workers can increase their productivity by 20%. Knowledge workers own the means of production — their brains. Knowledge management Managing people Productivity

How Pharma Companies Game the System to Keep Drugs Expensive

Harvard Business Review

The 1984 Drug Price Competition and Patent Term Restoration Act gave pharmaceutical companies exclusive protections for innovating a new drug. These aren’t really generic products at all; they are the same product sold under a generic name by the company that sells the branded drug. During this time, no other companies can market a generic product. Another way pharmaceutical firms are thwarting generics is by restricting access to samples for testing.

How to Take Your Manufacturing Business from Zero to Hero

Strategy Driven

From examining your current workflow to making significant changes to the production line, below are three ways you can take your business from zero to hero, and truly make your mark in the industry. Boosting employee productivity is essential in any business and manufacturing is no different.

Sexual Harassment Is Rampant in Health Care. Here’s How to Stop It.

Harvard Business Review

The negative effects of harassment also affect the well-being and productivity of colleagues and entire organizations. Organizational culture Gender Policy Corporate governance Healthcare Pharmaceuticals Digital ArticleCarmen Martínez Torrón/Getty Images.

How Pharma Can Offer More than Pills

Harvard Business Review

For years, there has been a push within the pharmaceutical industry to move “beyond the pill” — in other words, to build and deploy complementary services and solutions to diversify revenue sources.

How Pharma Can Fix Its Reputation and Its Business at the Same Time

Harvard Business Review

The business model of research-based pharmaceutical companies is under significant pressure. By that I mean that pharma companies should develop innovative treatments for pervasive unmet medical needs; avoid corruption, collusion, and other unethical marketing practices; and make sure that their products reach as many patients around the world as possible. The estimated return on these (fewer) products has itself declined substantially since 2010, from 10.1%

John Medina: An interview by Bob Morris

First Friday Book Synopsis

He has spent most of his professional life as a private research consultant, working primarily in the biotechnology and pharmaceutical industries on research related to mental health. John Medina is a developmental molecular biologist focused on the genes involved in human brain development and the genetics of psychiatric disorders.

Research: Innovation Suffers When Drug Companies Merge

Harvard Business Review

That can benefit consumers through lower prices, more innovation, and better products. This is especially true in pharmaceutical markets where new and affordable drugs can improve and even save the lives of many people.

Price 11

Fixing Pharma’s Incentives Problem in the Wake of the U.S. Opioid Crisis

Harvard Business Review

Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. Meanwhile, the amount of prescription opioids sold by pharmaceutical companies has quadrupled, despite no proliferation in the amount of reported pain.

Leap: How to Thrive in a World Where Everything Can Be Copied

Leading Blog

I N TODAY'S competitive environment, where latecomers can copy almost any product or service, companies can no longer just be good at what they do.

Is GSK taking the Sales out of Sales Rep?


It’s been over half a year since a potentially landmark event occurred in the pharmaceutical industry. I spent five years in the pharmaceutical industry, and had the chance to talk to many GSK representatives when the measures were announced. Most believed it was just a public relations stunt to try and present themselves as the “good guys” in pharmaceutical marketing – focused solely on customer needs.

Conflict-of-Interest Rules Are Holding Back Medical Breakthroughs

Harvard Business Review

Few issues are more foundational to driving improvements in human health than creating productive, progressive relationships between clinical medicine and the biopharmaceutical industry. Yet rarely do conflict-of-interest policies begin with a positive statement endorsing the importance of collaboration for successful translational research, advancing health, and enhancing the productivity of the biomedical enterprise.

Make Meaningful Work as Important as Results

Lead Change Blog

The only output they refer to is “superior value,” which doesn’t specify their product or service. The second example, from a pharmaceutical company, states their purpose is “to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.”

Is GSK taking the Sales out of Sales Rep?


It’s been over half a year since a potentially landmark event occurred in the pharmaceutical industry. I spent five years in the pharmaceutical industry, and had the chance to talk to many GSK representatives when the measures were announced. Most believed it was just a public relations stunt to try and present themselves as the “good guys” in pharmaceutical marketing – focused solely on customer needs.

A Simple Workaround to Overcome the Bureaucratic Mindset

Tanveer Naseer

Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas. Satellite component manufacturing can be complex to say the least, and it’s not uncommon for post-production testing to reveal flaws. Helping Employees Regain Their Productivity After A Prolonged Absence.

80% of Companies Don’t Know If Their Products Contain Conflict Minerals

Harvard Business Review

There are similar stories in the electronics industry, pet food, pharmaceuticals, and even national security. In 2010 Congress passed the Dodd–Frank Wall Street Reform and Consumer Protection Act, which included a provision, Section 1502, mandating that companies listed on American stock markets disclose whether their products contain conflict minerals: tantalum, tin, tungsten, and gold originating in the Democratic Republic of the Congo (DRC) or adjoining countries.

How Merck Is Trying to Keep Disrupters at Bay

Harvard Business Review

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

What Cancer Researchers Can Learn from Direct-to-Consumer Companies

Harvard Business Review

Unfortunately, far too many patients remain hesitant to share their health data, even though they routinely share all sorts of personal data when buying consumer products online. Organizations collecting patient data — including academic medical centers, foundations that sponsor cancer research, and pharmaceutical companies — must first identify the needs, pains, hopes, expectations, and behaviors of each person living with cancer.


Izell Leadership

In the first six months of work at the first job out of college as a pharmaceutical sales person, I was responsible to meeting with physicians to present my products. He did not look like someone who wanted to speak with a pharmaceutical sales person.

The Internet of Things Will Change Your Company, Not Just Your Products

Harvard Business Review

Here are some of the challenges that I’ve observed: Product management. Successful IoT plays require more than simply adding connectivity to a product and charging for service — something many companies don’t immediately understand. In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers.

Follow These 4 Tips to Increase Your Business Visibility

Strategy Driven

Is the general public familiar with your products and services? For instance, if you are a fashion company that promotes clothes and jump into the pharmaceutical industry out of the blue, you will confuse everyone. How widespread is your business’s brand awareness?

Tips 114

WHE01: 5 Components of Workforce Health Engagement

Engaging Leader

Workforce health engagement: improving the knowledge, decision-making, and behaviors of employees, their families, and organizational leaders to optimize health outcomes, control medical costs, and enhance workplace productivity.

Ethics Is Serious Business

Great Leadership By Dan

When does pharmaceutical pricing become price gouging? When does product promotion become false advertising? Guest post by John Hooker : Everyone knows that an organization can’t function without physical infrastructure communications, transportation, computer technology, and the rest. Yet we rely equally on social infrastructure. It consists of the social practices that allow us to relate successfully to coworkers, customers, investors, and the community at large.

Ethics 184

The Optimal Margin of Illusion

Great Leadership By Dan

The challenge, then, is to strike a productive balance between the confidence you need to be successful and the doubt you need to identify and address the weaknesses that matter. Promote Productive Fights.

Shaw 245

How To Be A More Effective Work-From-Home Employee

Eric Jacobson

Author Elaine Quinn wrote the book after working as a consultant for 10 years with small business owners who struggled with organization, time management, workflow processes, productivity and related challenges. More than 40 million people -- roughly one-third of the U.S.

There's No Place Like Working From Home

Eric Jacobson

Author Elaine Quinn wrote the book after working as a consultant for 10 years with small business owners who struggled with organization, time management, workflow processes, productivity and related challenges. About 42 million people -- roughly one-third of the U.S.

Quinn 75

Ready to Grow Your Business? How to Appeal to Niche Audiences

Strategy Driven

It’s a sure sign that the products or services that you are offering are quality and that you are providing customer satisfaction. When your operational and back office processes are aligned you work efficiently and productively.

Most Desired Trait by Companies Seeking Senior Executives

Great Leadership By Dan

years), while the pharmaceutical (5.7 years) and consumer products (6.1 I don''t often publish press releases, but this one from executive search firm IIC caught my attention and I thought it was worth sharing. It supports what I''ve been saying for years: It’s the Soft Stuff That’s Really the Hard Stuff and Why Do Businesses and Leaders Fail?


N2Growth Blog

Here is the rub and the reason why adopting this principle is so critical: in our experience, the priority initiatives turn out to be on new product, service, customer, and technology initiatives accompanied by an assumption that the organization has the capabilities to execute them. By Mark Hefner. Global Practice Chair, Strategy N2Growth. ADVANTAGE STRATEGY. Five Paradigm-Shifting Principles. Repeatable processes and procedures add great value in stable and predictable times.

A Message to Mylan’s CEO: Your Price Increase Wasn’t the Problem. Your Implementation Strategy Was.

The Kini Group

She’s enjoyed a 671% salary increase over the last decade while her company’s life-saving product, EpiPen®, has increased in price by 400% over the past five years. Is Mylan doing anything different from what other pharmaceutical companies have been doing for decades?

Price 40

6 Proven Tactics to Design an Effective Executive Healthcare Resume

Strategy Driven

Crafting and writing a branded healthcare executive resume, that differs from the traditional medical resume, can make a significant difference in your executive job search results and improve the opportunities to land that next-level position in pharmaceutical, biotech and medical device industries.

Problems with leadership development processes…


I was working with a major pharmaceutical company that had an internal two-week management development process.

How To Discover Your Organization’s Next Big Growth Opportunities

Tanveer Naseer

For example, they might say, “We’re a bank,” or “We make office furniture,” or “We’re in the pharmaceutical business.” The following is a guest piece by Innovation Excellence co-founder Rowan Gibson. Today’s corporate leaders are under intense pressure to deliver continuous business growth.

Silo Mentality: The Bane of Most Teams

Strategy Driven

A few years back, I coached a national pharmaceutical team with distinct geographies. One of the biggest frustrations expressed by business leaders of teams is the ‘silo mentality.’

Team 119